Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 25, 2015 - Issue 4
Submit an article Journal homepage
238
Views
4
CrossRef citations to date
0
Altmetric
Interview

A Key Opinion Leader interview: insight into the research and career of Prof. Claudiu T Supuran

Claudia PalmerCommissioning Editor,Expert Opinion Series, Informa Healthcare, Christchurch Court, 10-15 Newgate Street, London, EC1A 7AZ, UK
&
Claudiu T SupuranProfessor, University of Florence, Neurofarba Department, Via Ugo Schiff 6, Polo Scientifico, 50019 - Sesto Fiorentino (Firenze), Italy+39-055-4573729;   +39-055-4573005; [email protected]
Pages 501-505 | Published online: 10 Mar 2015

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Claudiu T. Supuran, Stanislav Kalinin, Muhammet Tanç, Pakornwit Sarnpitak, Prashant Mujumdar, Sally-Ann Poulsen & Mikhail Krasavin. (2016) Isoform-selective inhibitory profile of 2-imidazoline-substituted benzene sulfonamides against a panel of human carbonic anhydrases. Journal of Enzyme Inhibition and Medicinal Chemistry 31:sup1, pages 197-202.
Read now
Claudiu T. Supuran. (2016) How many carbonic anhydrase inhibition mechanisms exist?. Journal of Enzyme Inhibition and Medicinal Chemistry 31:3, pages 345-360.
Read now

Articles from other publishers (2)

Ye Hua & Quan Yuan. (2022) The launch of new products: New technology driven firm-user interactions with key opinion leaders for single and multiple interactions. Electronic Commerce Research and Applications 56, pages 101206.
Crossref
Mikhail Krasavin, Mikhail Korsakov, Zhanna Zvonaryova, Evgenii Semyonychev, Tiziano Tuccinardi, Stanislav Kalinin, Muhammet Tanç & Claudiu T. Supuran. (2017) Human carbonic anhydrase inhibitory profile of mono- and bis-sulfonamides synthesized via a direct sulfochlorination of 3- and 4-(hetero)arylisoxazol-5-amine scaffolds. Bioorganic & Medicinal Chemistry 25:6, pages 1914-1925.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.